New medication for treatment resistant depression added to PBS The nasal spray is available from 1 May to eligible patients, but a GP expert remains concerned about its accessibility.
Expanded PBS listing for empagliflozin An RACGP expert describes the change as a ‘double win’, with the 1 April expansion to benefit more patients with type 2 diabetes.
Is the Federal Election a ‘turning point’ for healthcare? Brandishing a Medicare card, Prime Minister Anthony Albanese has called a 3 May Federal Election, with GP access a central pillar for both major parties in the 2025 race to the polls.
What’s in the 2025–26 Federal Budget for GPs? The RACGP has welcomed GP workforce incentives but said while ‘it’s clear general practice is central in this year’s Budget’, there are still missed opportunities.
‘Not for sale’: Australia defends PBS against US big pharma GPs welcome plans to make PBS-listed medicines even cheaper, but it comes as US pharma giants take aim at the scheme.
‘The bane of my life’: Authority approvals under scrutiny A recent audit report has shed light on how one of the great admin burdens for general practice became even more onerous. What more can be done?
Prescriber reminder over oral contraceptive PBS changes Yaz and Yasmin are now available on the PBS – but existing patients will need a new prescription to access the lower price.
In Practice: EOIs for accredited training sites The RACGP is seeking to accredit new training sites in eligible GP catchments to address areas of workforce need across Australia.
Most GPs discover medication shortages through patients: Poll A new survey highlights the urgency of improving measures to communicate supply chain disruptions, with patients increasingly feeling an impact.
Prescriptions for most popular statins on the rise Data shows the number of people using the most popular statins is increasing, while the cost for COVID-19 antivirals has fallen.